Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.

Autor: Abebe, Muluye^1,2 (AUTHOR), Atnafu, Abay² (AUTHOR) ayatab.ayele7@gmail.com, Tilahun, Melaku² (AUTHOR), Sero, Nejmia³ (AUTHOR), Neway, Sebisib² (AUTHOR), Alemu, Mekdes² (AUTHOR), Tesfaye, Getachew² (AUTHOR), Mihret, Adane² (AUTHOR), Bobosha, Kidist² (AUTHOR), Wan, Chengsong¹ (AUTHOR)

Publikováno v: PLoS ONE. 5/31/2024, Vol. 19 Issue 5, p1-12. 12p.

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.

Autor: Mitnick CD; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA carole_mitnick@hms.harvard.edu., White RA; Dept of Infectious Disease Epidemiology, Norwegian Institute of Public Health, Oslo, Norway Dept of Health Statistics, Norwegian Institute of Public Health, Oslo, Norway., Lu C; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA., Rodriguez CA; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Bayona J; Socios en Salud Sucursal, Lima, Peru., Becerra MC; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA., Burgos M; Dept of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA., Centis R; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy., Cohen T; Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Cox H; Médecins Sans Frontières, Cape Town, South Africa., D'Ambrosio L; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland., Danilovitz M; Tartu University Hospital, Lung Clinic, Tartu, Estonia., Falzon D; Global TB Programme, World Health Organization, Geneva, Switzerland., Gelmanova IY; Partners in Health Russia, Moscow, Russia., Gler MT; Makati Medical Center, Manila, Philippines., Grinsdale JA; Tuberculosis Control, San Francisco Department of Public Health, San Francisco, CA, USA., Holtz TH; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Keshavjee S; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA., Leimane V; State Agency for Tuberculosis and Lung Diseases (TPSVA), Riga, Latvia., Menzies D; Montreal Chest Institute, McGill University, Montreal, QC, Canada., Migliori GB; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy., Milstein MB; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA., Mishustin SP; Tomsk TB and Pulmonary Medical Center, Tomsk Oblast, Russia., Pagano M; Dept of Biostatistics, Harvard School of Public Health, Boston, MA, USA., Quelapio MI; Tropical Disease Foundation, Philippine Institute of Tuberculosis, Makati City, Philippines., Shean K; Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Dept of Medicine, University of Cape Town, Cape Town, South Africa., Shin SS; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA Socios en Salud Sucursal, Lima, Peru., Tolman AW; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., van der Walt ML; South African Medical Research Council, Tuberculosis Research Platform, Pretoria, South Africa., Van Deun A; Institute of Tropical Medicine, Antwerp, Belgium., Viiklepp P; National Institute for Heath Development, Tallinn, Estonia.

Publikováno v: The European respiratory journal [Eur Respir J] 2016 Oct; Vol. 48 (4), pp. 1160-1170. Date of Electronic Publication: 2016 Sep 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects.

Autor: Kurbatova EV; U.S. Centers for Disease Control and Prevention, International Research and Programs Branch, Division of Tuberculosis Elimination, Atlanta, GA 30333, USA. EKurbatova@cdc.gov, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP

Publikováno v: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2012 Sep; Vol. 92 (5), pp. 397-403. Date of Electronic Publication: 2012 Jul 10.

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.

Autor: Kherabi, Yousra^1,2 yousra.kherabi@aphp.fr, Fréchet-Jachym, Mathilde³, Rioux, Christophe⁴, Yazdanpanah, Yazdan^1,4,5,6, Méchaï, Frédéric^7,8, Pourcher, Valérie⁹, Robert, Jérôme², Guglielmetti, Lorenzo^2,10, MDR-TB Management Group (CORPORATE AUTHOR)

Publikováno v: Emerging Infectious Diseases. Sep2022, Vol. 28 Issue 9, p1796-1804. 9p.